Alice Shaw, MD, Ph.D, GRACE Faculty

Alice Shaw, MD, Ph.D, Director of the Center for Thoracic Cancers
Massachusetts General Hospital
Boston
MA
Specialties
Thoracic Cancers

Alice T. Shaw is the Director of the Center for Thoracic Cancers and the Paula O’Keeffe Endowed Chair of Thoracic Oncology at Massachusetts General Hospital. She is also an Associate Professor of Medicine at Harvard Medical School. She received her A.B. in Biochemistry from Harvard and her M.D. and Ph.D. degrees from Harvard Medical School. She did her residency in Internal Medicine at Massachusetts General Hospital and completed a fellowship in Hematology/Oncology at Dana-Farber/Massachusetts General Hospital. She completed her postdoctoral work in the laboratory of Dr. Tyler Jacks at MIT.

In addition to caring for patients with lung cancer, Dr. Shaw also performs clinical and translational research. Her clinical research focuses on a variety of different molecularly defined subsets of non-small cell lung cancer (NSCLC). Her translational research focuses on elucidating mechanisms of resistance to targeted therapies. Based on her research, she has helped to develop numerous FDA-approved targeted therapies for patients with oncogene-driven NSCLC, and her current efforts focus on developing novel combinatorial strategies aimed at overcoming drug resistance.

Dr. Shaw has been awarded a number of research grants, including grants from the Damon Runyon Cancer Research Foundation, the Burroughs Wellcome Fund, the V Foundation for Cancer Research, Uniting Against Lung Cancer, the National Foundation for Cancer Research, SU2C/AACR/ACS, and the NIH/NCI. In 2014 she was elected as a member to the American Society of Clinical Investigation. She is a standing member of the FDA Oncologic Drugs Advisory Committee and she recently joined the LUNGevity Foundation Scientific Advisory Board.

Conflict of Interest

None

Dr. Alice Shaw joined GRACE to discuss the changing landscape of first-line treatment of ALK-positive advanced non-small cell lung cancer.

Dr. Alice Shaw joined GRACE to discuss patterns of resistance in ALK positive non small cell lung cancer.

Dr. Alice Shaw joined GRACE to discuss controlling brain metastases in patients with molecular driven advanced non-small cell lung cancer.

Community Forum

JOIN THE CONVERSATION

Thought I should add that I am 65, former 30 yr smoker quit 8 yrs ago. Otherwise active and decent health. I will welcome any insight/answers to my questions whether to...

Hi and welcome to Grace,

I'm sorry you're going through this scare. I can't say if the 7mm growth in 7 years will or won't be a problem in the rather...

How does this forum work. Are community members able to reply to posts, or just moderators? Thanks

Usually the conversation is between the op and mod and/or faculty though we would like to have other members join in to share experiences, knowledge, and support. more heads are better...

Hi Michel, Welcome to Grace though I'm very sorry you are here.

Blood/liquid biopsies can detect cancer cells but usually only if there are a lot of cancer cells circulating. So...